{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:32:51Z","timestamp":1793500371569,"version":"4.5.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T00:00:00Z","timestamp":1182902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0000542","type":"journal-article","created":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T20:00:44Z","timestamp":1182888044000},"page":"e542","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["An Open Randomized Comparison of Gatifloxacin versus Cefixime for the Treatment of Uncomplicated Enteric Fever"],"prefix":"10.1371","volume":"2","clinical-trial-number":[{"clinical-trial-number":"isrctn75784880","registry":"10.18810\/isrctn"}],"author":[{"given":"Anil","family":"Pandit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Arjyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddhi","family":"Paudyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Dangol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Stepniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James I.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Dolecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddha","family":"Basnyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2007,6,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid Fever.","volume":"347","author":"CM Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(05)67181-4","article-title":"Typhoid and paratyphoid fever.","volume":"366","author":"M Bahn","year":"2005","journal-title":"Lancet"},{"key":"ref3","first-page":"346","article-title":"The global burden of typhoid fever.","volume":"82","author":"JA Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"ref4","first-page":"CD004530","article-title":"Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).","volume":"18","author":"D Thaver","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7326\/0003-4819-29-1-131","article-title":"Preliminary report on the beneficial effect of chloromycetin in the treatment of typhoid fever.","volume":"29","author":"TE Woodward","year":"1948","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1580\/1080-6032(2004)15[216:PROTBE]2.0.CO;2","article-title":"Preliminary report of the beneficial effect of chloromycetin in the treatment of typhoid fever, a commentary.","volume":"15","author":"B Basnyat","year":"2004","journal-title":"Wilderness Environ Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(99)01001-6","article-title":"Ciprofloxacin-resistant Salmonella typhi and treatment failure.","volume":"353","author":"EJ Threlfall","year":"1999","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/497136","article-title":"Enteric fever (typhoid) fever in travellers.","volume":"41","author":"B Basnyat","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/503033","article-title":"Salmonella enterica Typhi and Paratyphi A cause indistinguishable clinical syndromes in Kathmandu, Nepal.","volume":"42","author":"AP Maskey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref10","article-title":"Treatment of typhoid fever. Background document: the diagnosis, prevention and treatment of typhoid fever.","year":"2003"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(05)67653-2","article-title":"Typhoid and paratyphoid fever.","volume":"366","author":"A Pandit","year":"2005","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1128\/AAC.49.3.1106-1112.2005","article-title":"Pharmacokinetics of gatifloxacin in infants and children.","volume":"49","author":"EV Capparelli","year":"2005","journal-title":"Antimcrob Agents Chemother"},{"key":"ref13","first-page":"503","article-title":"Typhoid and paratyphoid fevers.","author":"J Richens","year":"2003"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006454-199903000-00007","article-title":"A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children.","volume":"18","author":"XT Cao","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.2004.70.670","article-title":"The etiology of febrile illness in adults presenting to Patan Hospital in Kathmandu, Nepal.","volume":"70","author":"DR Murdoch","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","first-page":"897","article-title":"Salmonellosis.","author":"FL Cammie","year":"2005"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diagmicrobio.2005.10.016","article-title":"Decreased susceptibility to fluroquinolones and <italic>gyr A<\/italic> gene mutation in the <italic>Salmonella enterica<\/italic> serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.","volume":"54","author":"T Shirakawa","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","article-title":"A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.","volume":"44","author":"NT Chinh","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","first-page":"57","article-title":"Enteric fever: is ciprofloxacin failing in Nepal?","volume":"35","author":"I Ansari","year":"2005","journal-title":"Trop Doct"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/AAC.43.12.2969","article-title":"Gatifloxacin activity against quinolone resistant gyrase: Allele specific enhancement of bacteriostatic bactericidal activities by the C-8 methoxy group.","volume":"43","author":"T Lu","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1128\/AAC.45.9.2450-2454.2001","article-title":"Mechanism of therapeutic effectiveness of cefixime against typhoid fever.","volume":"45","author":"Y Matsumoto","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0091270004273679","article-title":"Tissue penetration of cefpodoxime and cefixime in healthy subjects.","volume":"45","author":"P Liu","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"ref23","first-page":"1182","article-title":"Typhoid Fever.","volume":"248","author":"CM Parry","year":"2003","journal-title":"New Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-141-12-200412210-00022","article-title":"Hypoglycemia, hyperglycemia and gatifloxacin.","volume":"141","author":"W Khovidhunit","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428847","article-title":"Gatifloxacin therapy associated with hypoglycemia.","volume":"40","author":"AL Greenberg","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1345\/aph.1D360","article-title":"Possible gatifloxacin induced hyperglycemia.","volume":"38","author":"AR Donaldson","year":"2004","journal-title":"Ann Pharmacother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMoa055191","article-title":"Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults.","volume":"354","author":"LY Park-Wyllie","year":"2006","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/431584","article-title":"Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and\/or AOM treatment failure.","volume":"41","author":"ME Pichichero","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref29","first-page":"163","article-title":"A comparative study of cefixime and chloramphenicol in children with typhoid fever.","volume":"48","author":"MW Rabbani","year":"1998","journal-title":"J Pak Med Assoc"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/00007611-199712000-00008","article-title":"Cefixime: an oral option for the treatment of multidrug resistant enteric fever in children.","volume":"90","author":"IA Memon","year":"1997","journal-title":"South Med J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00006454-199507000-00010","article-title":"Comparison of the efficacy, safety, and cost of cefixime, ceftriaxone, and aztreonam in the treatment of multi drug resistant Salmonella Typhi septicemia in children.","volume":"14","author":"NI Girgis","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"ref32","first-page":"47","article-title":"Cefixime in the treatment of enteric fever in children.","volume":"19","author":"NI Girgis","year":"1993","journal-title":"Drugs Exp Clin Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/00006454-199411000-00010","article-title":"Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone.","volume":"13","author":"ZA Bhutta","year":"1994","journal-title":"Pediatr Infect Dis J"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0000542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:30:24Z","timestamp":1588966224000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0000542"}},"subtitle":[],"editor":[{"given":"David","family":"Lalloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,6,27]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,6,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0000542","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,27]]}}}